Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB. Tadolini M, et al. Among authors: hewison c. Eur Respir J. 2016 Sep;48(3):938-43. doi: 10.1183/13993003.00705-2016. Epub 2016 Jun 23. Eur Respir J. 2016. PMID: 27338197 Free PMC article.
Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They?
Bastard M, Guglielmetti L, Huerga H, Hayrapetyan A, Khachatryan N, Yegiazaryan L, Faqirzai J, Hovhannisyan L, Varaine F, Hewison C. Bastard M, et al. Among authors: hewison c. Am J Respir Crit Care Med. 2018 Nov 1;198(9):1228-1231. doi: 10.1164/rccm.201801-0019LE. Am J Respir Crit Care Med. 2018. PMID: 29969054 No abstract available.
High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.
Huerga H, Sanchez-Padilla E, Melikyan N, Atshemyan H, Hayrapetyan A, Ulumyan A, Bastard M, Khachatryan N, Hewison C, Varaine F, Bonnet M. Huerga H, et al. Among authors: hewison c. Arch Dis Child. 2019 Jul;104(7):622-628. doi: 10.1136/archdischild-2018-315411. Epub 2018 Dec 6. Arch Dis Child. 2019. PMID: 30523172 Free PMC article.
In reply.
Hewison C, Bastard M, Varaine F, Huerga H. Hewison C, et al. Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1524-1525. doi: 10.5588/ijtld.18.0472-2. Int J Tuberc Lung Dis. 2018. PMID: 30606328 No abstract available.
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Mbuagbaw L, Guglielmetti L, Hewison C, Bakare N, Bastard M, Caumes E, Fréchet-Jachym M, Robert J, Veziris N, Khachatryan N, Kotrikadze T, Hayrapetyan A, Avaliani Z, Schünemann HJ, Lienhardt C. Mbuagbaw L, et al. Among authors: hewison c. Emerg Infect Dis. 2019 May;25(5):936-943. doi: 10.3201/eid2505.181823. Emerg Infect Dis. 2019. PMID: 31002070 Free PMC article.
87 results